Recombinogenic activity of fluoxetine in Aspergillus nidulans

References

• Arnaudeau, C., Tenorio Miranda, E., Jensen, D., Helleday, T. (2000). Inhibition of DNA synthesis is a potent mechanism by which cytostatic drugs induce homologous recombination in mammalian cells. Mutat Res 461:221–228.
   PubMed Web of Science ®Google Scholar
• Becker, T. C. A., Castro-Prado, M. A. A. (2004). Parameiosis in Aspergillus nidulans in response to doxorubicin. Folia Microbiol 49:699–704.
   PubMed Web of Science ®Google Scholar
• Bergen, G. G., Morris, N. R. (1983). Kinetics of the nuclear division cycle of Aspergillus nidulans. J Bacteriol 156:155–160.
   PubMed Web of Science ®Google Scholar
• Blackburn, A. C., McLary, S. C., Naeem, R., Luszcz, J., Stockton, D. W., Donehower, L. A., et al. (2004). Loss of heterozygosity occurs via mitotic recombination in Trp53+/− mice and associates with mammary tumor susceptibility of the Balb/c strain. Cancer Res 64:5140–5147.
   PubMed Web of Science ®Google Scholar
• Bozkurt, G., Abay, E., Ates, I., Karabogaz, G., Ture, M., Savran, F. O., et al. (2004). Clastogenicity of selective serotonin-reuptake inhibitors. Mutat Res 558:137–144.
   PubMed Web of Science ®Google Scholar
• Cavenee, W. K., Scrable, H. J., James, C. D. (1991). Molecular genetics of human cancer predisposition and progression. Mutat Res 247:199–202.
   PubMed Web of Science ®Google Scholar
• Collins, K., Jacks, T., Pavletich, N. P. (1997). The cell cycle and cancer. Proc Natl Acad Sci U S A 94:2776–2778.
   PubMed Web of Science ®Google Scholar
• Fava, M., Kaji, J. (1994). Continuation and maintenance treatment of major depressive disorder. Psychiatr Ann 42:281–290.
   Google Scholar
• Ferguson, J., Hill, H. (2003). The pharmacokinetics of fluoxetine in elderly volunteers ages 65–85. Eur Neuropsychopharmacol 13:181–181.
   Web of Science ®Google Scholar
• Fernandes, A., Hoeck, E. V., Sandra, P., Lanc, F. M. (2008). Determination of fluoxetine in plasma by gas chromatography–mass spectrometry using stir bar sorptive extraction. Anal Chem Acta 614:201–207.
   PubMed Web of Science ®Google Scholar
• Fisch, M. (2004). Treatment of depression and cancer. J Natl Cancer Inst Monogr 32:105–111.
   PubMedGoogle Scholar
• Frick, L. R., Palumbo, M. L., Zappia, M. P., Brocco, M. A., Cremaschi, G. A., Genaro, A. M. (2008). Inhibitory effect of fluoxetine on lymphoma growth through the modulation of antitumor T-cell response by serotonin-dependent and independent mechanisms. Biochem Pharmacol 75:1817– 1826.
   PubMed Web of Science ®Google Scholar
• German, J. (1993). Bloom syndrome: a Mendelian prototype of somatic mutational disease. Medicine 72:393–406.
   PubMed Web of Science ®Google Scholar
• Helen, K. D. B., Subramanyam, S. (1991). Genotoxic evaluation of ara-c by multiple parameters. Mutat Res 263:185–196.
   PubMed Web of Science ®Google Scholar
• Jirkova, K., Mandys, V., Gispen, W. H., Bar, P. R. (2006). Cisplatin-induced apoptosis in cultures of human Schwann cells. Neurosci Lett 392:22–26.
   PubMed Web of Science ®Google Scholar
• Lasko, D., Cavenee, W., Nordenskjold, M. (1991). Loss of constitutional heterozygosity in human cancer. Ann Rev Genet 25:281–314.
   PubMed Web of Science ®Google Scholar
• Luo, G., Santoro, I. M., McDaniel, L. D., Nishijima, I., Mills, M., Youssoufian, H., et al. (2000). Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nat Genet 26:424–429.
   PubMed Web of Science ®Google Scholar
• Maertens, O., Prenen, H., Debiec-Rychter, M., Wozniak, A., Sciot, R., Pauwels, P., et al. (2006). Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients. Hum Mol Genet 15:1015–1023.
   PubMed Web of Science ®Google Scholar
• Miyamoto, C. T., Sant’Anna, J. R., Franco, C. C. S., Castro-Prado, M. A. A. (2007). Genotoxicity (mitotic recombination) of the cancer chemotherapeutic agents, cisplatin and cytosine arabinoside, in Aspergillus nidulans. Food Chem Toxicol 45:1091–1095.
   PubMed Web of Science ®Google Scholar
• Offer, H., Erez, N., Zurer, I., Tang, X., Milyavsky, M., Goldfinger, N., et al. (2002). The onset of p53-dependent DNA repair or apoptosis is determined by the level of accumulated damaged DNA. Carcinogenesis 23:1025–1032.
   PubMed Web of Science ®Google Scholar
• Portteus, A., Ahmad, N., Tobey, D., Leavery, P. L. (2006). The prevalence and use of antidepressant medication in pediatric cancer patients. J Child Adolesc Psychopharmacol 16:467–473.
   PubMed Web of Science ®Google Scholar
• Qian, F., Germino, G. G. (1997). Somatic genetics’ 97 “Mistakes Happen”: somatic mutation and disease. Am J Hum Genet 61:1000–1005.
   PubMed Web of Science ®Google Scholar
• Roper, J. A. (1952). Production of heterozygous diploids in filamentous fungi. Experientia 8:14–15.
   PubMedGoogle Scholar
• Serafein, A., Holder, M. J., Grafton, G., Chamba, A., Drayson, M. T., Luong, Q. T., et al. (2003). Selective serotonin inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells. Blood 101:3212–3219.
   PubMed Web of Science ®Google Scholar
• Serra, E., Rosenbaum, T., Nadal, M., Winner, U., Ars, E., Estivill, X., et al. (2001). Mitotic recombination effects homozygosity for NF1 germline mutations in neurofibromas. Nat Genet 28:294–296.
   PubMed Web of Science ®Google Scholar
• Shao, C., Deng, L., Henegariu, O., Liang, L., Raikwar, N., Sahota, A., Stambrook, P.J., Tischfield, J.A. (1999). Mitotic recombination produces the majority of recessive fibroblast variants in heterozygous mice. Proc. Natl. Acad. Sci. USA. 96: 9230–9235.
   PubMed Web of Science ®Google Scholar
• Sternbach, H. (2003). Are antidepressants carcinogenic? A review of preclinical and clinical studies. J. Clin. Psychiatry. 64: 1153–1162.
   PubMed Web of Science ®Google Scholar
• Stewart, D. R., Corless, C. L., Rubin, B. P., Heinrich, M. C., Messiaen, L. M., Kessler, L. J., et al. (2007). Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1. J Med Genet 44:e61.
   PubMed Web of Science ®Google Scholar
• Tanaka, K., Mansoor, A. M., Shigeta, C., Oguma, N., Kamada, N. (1992). Loss of heterozygosity at D3S2 locus of short arm of chromosome 3 in chronic myelogenous leukemia. Cancer Genet Cytogenet 61:42–45.
   PubMed Web of Science ®Google Scholar
• Uppin, M. S., Paul, T. R., Rajappa, S., Gayathri, K., Jacob, R., Uppin, S. G. (2007). Leukemia as a second malignancy. Ind J Pathol Microbiol 50:644–647.
   PubMedGoogle Scholar
• van der Heijden, M. S., Yeo, C. J., Hruban, R. H., Kern, S. E. (2003). Fanconi anemia gene mutations in young-onset pancreatic cancer. Cancer Res 63:2585–2588.
   PubMed Web of Science ®Google Scholar
• Vancura, R. W., Kepes, J. J., Newell, K. L., Ha, T. M., Arnold, P. M. (2006). Secondary intracranial neoplasms exhibiting features of astrocytoma and neuroblastoma in 2 children treated for acute lymphoblastic leukemia: report of 2 cases. Surg Neurol 65:490–494.
   PubMed Web of Science ®Google Scholar
• Yamada, T., Shinohara, K., Takeda, K., Kamed, N., Katsuki, K., Ariyoshi, K., et al. (1999). Second lung adenocarcinoma after combination chemotherapy in two patients with primary non-Hodgkin’s lymphoma. Jpn J Clin Oncol 29:226–228.
   PubMed Web of Science ®Google Scholar
• Young, B. D., Debernardi, S., Lilington, D. M., Skoulakis, S., Chaplin, T., Foot, N. J., et al. (2006). A role for mitotic recombination in leukemogenesis. Adv Enzyme Regul 46:90–97.
   PubMedGoogle Scholar